Northwest Investment Counselors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$54.6K Buy
+105
New +$56.1K 0.01% 240
2024
Q2
Sell
-105
Closed -$54.4K 240
2024
Q1
$54.4K Buy
+105
New +$52.2K 0.01% 225
2023
Q4
Sell
-105
Closed -$45.7K 242
2023
Q3
$45.7K Hold
105
0.01% 235
2023
Q2
$46.6K Hold
105
0.01% 248
2023
Q1
$48.3K Hold
105
0.01% 247
2022
Q4
$53.9K Hold
105
0.02% 234
2022
Q3
$48K Hold
105
0.02% 218
2022
Q2
$51K Sell
105
-4
-4% -$1.98K 0.02% 213
2022
Q1
$54K Buy
109
+4
+4% +$1.83K 0.01% 222
2021
Q4
$49K Buy
+105
New +$44.2K 0.01% 231
2021
Q2
Sell
-39
Closed -$14K 227
2021
Q1
$14K Buy
+39
New +$12.5K ﹤0.01% 329
2020
Q4
Sell
-39
Closed -$10K 224
2020
Q3
$10K Buy
+39
New +$10.5K ﹤0.01% 324
2019
Q4
Sell
-39
Closed -$9K 245
2019
Q3
$9K Buy
+39
New +$10.7K ﹤0.01% 362

Other funds holding ELV

Northwest Investment Counselors's ELV Position: Q3 2024 in Review

Northwest Investment Counselors opened a new position in Elevance Health (ELV) in Q3 2024: 105 shares worth $54.6K. The stake represents 0.01% of the portfolio and ranks #240 among its holdings. This is a return to the name: Northwest Investment Counselors previously reported a position in ELV as recently as Q1 2024.

Northwest Investment Counselors first reported a position in ELV in Q3 2019 and has held it in 13 quarters since. 1,694 funds tracked by Wall St. Rank hold ELV as of Q3 2024.

  • Northwest Investment Counselors held 105 shares of Elevance Health worth $54.6K as of Q3 2024.
  • Elevance Health was a new Northwest Investment Counselors position in Q3 2024.
  • Elevance Health made up 0.01% of Northwest Investment Counselors's portfolio in Q3 2024, its #240 holding.
  • Northwest Investment Counselors first reported a position in Elevance Health in Q3 2019 and has held it in 13 quarters since.
  • 1,694 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.

Based on Northwest Investment Counselors's 13F filing for Q3 2024, filed 21 Oct 2024.